The molecular biology of RU486. Is there a role for antiprogestins in the treatment of breast cancer?
Horwitz
K B
KB
Department of Medicine, University of Colorado Health Sciences Center, Denver 80262.
D000818:Animals; D001940:Breast / Q000378:metabolism; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D004247:DNA / Q000378:metabolism; D015536:Down-Regulation; D005260:Female; D006801:Humans; D015735:Mifepristone / Q000494:pharmacology* / Q000627:therapeutic use; D011374:Progesterone / Q000037:antagonists & inhibitors / Q000494:pharmacology / Q000502:physiology*; D011980:Receptors, Progesterone / Q000378:metabolism; D014158:Transcription, Genetic / Q000187:drug effects; D014407:Tumor Cells, Cultured
D011980:Receptors, Progesterone; D015735:Mifepristone; D011374:Progesterone; D004247:DNA